Prestige Consumer Healthcare (PBH) Capital Expenditures Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 6.52% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 232.22% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 34.64% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 147.53% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 28.56% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -15.83% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | -61.38% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 89.86% |
| 10 | Prestige Consumer Healthcare | 2.39 Bn | 2.33 Bn | 157.37 Mn | 18.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.86% |
| Sep 30, 2025 | -4.00% |
| Jun 30, 2025 | -7.15% |
| Mar 31, 2025 | 3.25% |
| Dec 31, 2024 | -11.10% |
| Sep 30, 2024 | -9.69% |
| Jun 30, 2024 | -8.42% |
| Mar 31, 2024 | -13.74% |
| Dec 31, 2023 | -29.63% |
| Sep 30, 2023 | -31.34% |
| Jun 30, 2023 | -16.67% |
| Mar 31, 2023 | -22.55% |
| Dec 31, 2022 | -17.69% |
| Sep 30, 2022 | -14.98% |
| Jun 30, 2022 | -18.81% |
| Mar 31, 2022 | -1.83% |
| Dec 31, 2021 | 2.58% |
| Sep 30, 2021 | 1.85% |
| Jun 30, 2021 | -15.31% |
| Mar 31, 2021 | 19.40% |